My name is Jaroslaw (Jaro) Wechowski and I am a physician and a health economist working in the area of health economic (pharmacoeconomic) modelling and public health. I am particularly interested in modelling preventive interventions (primary and secondary prevention). The topic of my PhD dissertation was "Financing and efficiency of health systems - preventive paradigm".
Currently I am a director of Pharmarchitecture Limited, an independent health outcomes / health technology assessment consulting company. If you you are interested in collaboration in the area of health outcomes, health technology assessment or pharmacoeconomics, particularly in evidence synthesis, cost-effectiveness modelling and data analysis, please get in touch.
Here are my conference presentations and publications:
Conference presentations and posters:
· Slawik M, Plisko R, Landa K, Wechowski J. Comparison of efficacy and cost-effectiveness of surgery with pharmacological treatment as exemplified by laparoscopic Nissen fundoplication and omeprazole (in Polish). The 7th Warsaw Cardiological Pharmacotherapy Conference, 23-24 June 2005.
· Wechowski J, Woehl A, Tetlow T, McEwan P, Connolly M, Bhatt A, Burroughs A, Currie CJ. Cost-utility analysis in the UK setting of vasoactive drug treatments in acute bleeding oesophageal varices in cirrhotic patients – a discrete event simulation model. ISPOR 9th Annual European Congress 29-31 October 2006, Copenhagen, Denmark.
· Wechowski J, Poole C, Currie CJ. The short term cost-effectiveness of 46 surgical procedures in the United Kingdom. ISPOR 11th Annual International Meeting 20-24 May 2006, Philadelphia, USA (poster).
· Wechowski J, Plisko R, Wladysiuk-Blicharz M, Landa K. Survival analysis and cost-effectiveness analysis of mammotomy, core biopsy and fine needle aspiration biopsy in the diagnostics of non-palpable breast lesions: a decision analytic model. 3rd Annual Meeting of Health Technology Assessment International (HTAi), Adelaide, 3-5 July 2006.
· Wechowski J, Tetlow T, Woehl A, Connolly M, Currie CJ, Burroughs A. An economic evaluation of terlipressin versus alternative vasoactive drug treatments for acute oesophageal variceal bleeding in cirrhotic patients: a UK decision-analytic model. United European Gastroenterology Week. 21 – 25 October 2006, Berlin, Germany (poster).
· Wechowski J, Tetlow T, Woehl A, Currie CJ, Connolly M, Bhatt A, Colle Economic evaluation of vasoactive management options for acute oesophageal variceal bleeding in cirrhotic patients: A Belgian comparison. Prague Hepatology Meeting 13-16 September 2006, Prague, Czech Republic. Abstract published in: Ceska a Slovenska Gastrologie a Hepatologie 2006;60,S1,119.
· Wechowski J, McEwan, Connolly M, Kennedy R. Costs and effectiveness of highly purified human menopausal gonadotropin (HP-hMG) versus recombinant follitropin alpha (rFSH) in IVF treatment: A discrete event simulation model. 19th World Congress on Fertility and Sterility. International Federation of Fertility Societies, April 2007, Durban, South Africa.
· Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J. Costs of peritoneal dialysis and haemodialysis in a UK setting – a microcosting approach. Renal Association Annual Meeting, Brighton, May 21-23 2007 (poster).
· Wechowski J, McEwan P. Cost-utility of identifying patients with Impaired Glucose Tolerance and their subsequent treatment with intensive lifestyle intervention to delay the onset of type 2 diabetes in the UK setting. IV Annual Health Technology Assessment Meeting, Barcelona, 17-20 June 2007.
· Wechowski J, McEwan P, Connolly M, Kennedy R. An economic evaluation of highly purified human menopausal gonadotropin (HP-hMG) versus recombinant follitropin alpha (rFSH) in IVF treatment using two large combined randomised controlled trials. The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, Lyon, France, 1-4 July 2007.
· Wechowski J, Spiewanowski P, McEwan P. Temporal patterns in health related quality of life in hospitalized patients in the United Kingdom. ISPOR 10th Annual European Congress, October 2007, Dublin, Ireland (poster).
· Baboolal K, Spiewanowski P, McEwan P, Sondhi S, Wilson K, Wechowski J. Cost of dialysis in a UK setting - a multicentre microcosting study. ISPOR 10th Annual European Congress, October 2007, Dublin, Ireland (poster).
HTA reports and other publications (not peer-reviewed):
· Hetnal M, Wechowski J. Comparison of efficacy and safety of selected diagnostic methods of non-palpable breast lesions, HTA Consulting, Krakow 2004.
· Wechowski J, Plisko R. Survival analysis and cost-effectiveness analysis of Mammotomy, Core Biopsy and Fine Needle Aspiration Biopsy in the diagnostics of non-palpable breast lesions: a decision analytic model, HTA Consulting, Krakow 2005.
· Wechowski J, Hetnal M. Comparison of efficacy and cost-effectiveness of gastric banding with selected options in the treatment of morbid obesity and severe obesity with comorbidity, HTA Consulting, Krakow 2005 (in Polish).
· Siwiec J, Gasiorowski M, Wechowski J, Wladysiuk-Blicharz M, Landa K. Comparison of efficacy and cost-effectiveness of omalizumab with placebo and with standard treatment in moderate to severe allergic asthma, HTA Consulting, Krakow 2005 (in Polish).
· Wechowski J, Plisko R. Comparison of efficacy, safety and cost-effectiveness of sevelamer and calcium-based phosphate binders in hyperphosphataemic patients with chronic kidney disease (exploratory report), HTA Consulting, Krakow 2005.
· Wechowski J. Health insurance in the United States. In: Health Insurance in Central and Eastern Europe – the beginning of the road, Holly R. (ed). Insurance Institute in Poland, Warszawa 2001 (in Polish).
· Currie C, Wechowski J. Randomized single versus double embryo transfer studies: obstetric and paediatric outcome and a cost-effectiveness analysis. Letter to the editor. Hum Rep 2006;21,1939-40.
Peer-reviewed publications:
· Wechowski J, Woehl A, Tetlow T, McEwan P, Connolly M, Bhatt A, Burroughs A. Currie CJ. An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis. Curr Med Res Opin 2007;7,1487-1491.
· Wechowski J, Connolly M, McEwan P, Kennedy R. Cost-saving treatment strategies in IVF: An economic evaluation based on a randomised clinical trial comparing highly purified human menopausal gonadotropin and recombinant follitropin alpha. (Reprod BioMed Online 2007;15(5),500–506.